-
Mashup Score: 0
The money also will help fund clinical trials for additional indications and the expansion of its manufacturing capabilities.
Source: www.medtechdive.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Patient Stories Archive - 7 month(s) ago
I Was Told I Was Too Young for Blood Clots: Audrey’s Story At 20 years old, I was healthy, fit, active, and recovering from an ACL tear from a year and a half prior. When I finally went in for reconstructive surgery on June 19, 2020, it was at the height of the COVID-19 pandemic, already a very stressful time. I was aware that I had a… My Neighbor Found Me and Performed CPR: Jessica’s…
Source: Blood ClotsCategories: Cardiology News and Journals, Latest HeadlinesTweet-
"I had an emergency #thrombectomy to break up the #bloodclot. Because of the #PE paired with pneumonia, we found that my lung was partially dead, which is known as #infarction." Full story: https://t.co/mAsKg2DTRc #stoptheclot #stoptheclotstory #factorvleiden #pulmonaryembolism https://t.co/j8kBtJBPYm
-
-
Mashup Score: 0Dodging a Bullet - 8 month(s) ago
Looking at a unique case.
Source: www.hmpgloballearningnetwork.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Dr. Pradeep Nair comments on a unique case where clinicians had to think creatively to utilize a tool intended for #thrombectomy cases to avoid catastrophic consequences of foreign body vascular #embolization. The foreign body? A bullet. https://t.co/i4hZcL7X75 https://t.co/3CHpGd5v95
-
-
Mashup Score: 0The Hematologist Told Me to Buy a Lottery Ticket For How Lucky I’d Been: McKenna’s Story - 8 month(s) ago
In 2021, I started to experience extreme back pain. At times, I was unable to sit down or move at all. I thought it was a tweak.
Source: www.stoptheclot.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
"During my week in the hospital, I went through two #thrombectomy procedures. Doctors also discovered that I have #MayThurnerSyndrome & #FactorII heterozygous clotting disorder." Full story: https://t.co/AAyFBjT1t5 #stoptheclot #stoptheclotstory #mts #birthcontrol https://t.co/qRUiibNJG3
-
-
Mashup Score: 0We Lost Our Son at the Age of 20: Adam's Story - 9 month(s) ago
On Dec. 3, 2020, I took my 18-year-old son, Adam, to the ER. He had severe back and leg pain, and his leg was swollen and purple.
Source: www.stoptheclot.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
"On Dec. 3, 2020, I took my 18-year-old son, Adam, to the ER. He had severe back and leg pain, and his leg was swollen and purple." Read Adam's story: https://t.co/9vkqz5cIVG #stoptheclot #stoptheclotstory #pulmonaryembolism #factorvleiden #maythurnersyndrome #dvt #thrombectomy https://t.co/ty2lo5cfup
-
-
Mashup Score: 0
Basilar artery occlusion (BAO) is an uncommon event, and leads to poor outcome in an estimated 60 to 80% of patients. Two early randomized trials, BASICS and BEST demonstrated equivocal benefit of endovascular therapy (EVT) compared to medical management. These trials helped in forming the design, s …
Source: PubMedCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Endovascular therapy for basilar artery occlusion #stroke #thrombectomy https://t.co/EEob6aNAvh
-
-
Mashup Score: 0Dual Therapy Following Iliocaval and Iliofemoral Deep Vein Thrombosis Thrombectomy: An Interview With Dr. Gregg Khodorov - 11 month(s) ago
VDM spoke with Dr. Khodorov to discuss the results of the study and what it means for dual therapy regimens for 12-month patency.
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Dual Therapy Following Iliocaval and Iliofemoral Deep Vein Thrombosis #Thrombectomy In this interview, Dr @GreggKhodorov discusses study results he presented at #SIR2023 and what it means for dual therapy regimens for 12-month patency: https://t.co/GajN7eD6db https://t.co/bu0uJiPIhK
-
-
Mashup Score: 2Global Trends in Thrombectomy Device and Systems Development: Retrospective Review Between 2000 and 2022 - 11 month(s) ago
Purpose: Novel technologies have shaped modern techniques in endovascular thrombectomy to ultimately improve outcomes for high-risk or critically ill patients.
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
In this abstract submitted to #ISET2023, the authors outline their study that examined global trends in thrombectomy device and systems development over the past 2 decades. Learn more on VDM's #Thrombectomy Topic Center: https://t.co/BbOp3lb94w https://t.co/AQH8pnRkHj
-
-
Mashup Score: 1I Remained on Life Support For Four Days: Felecia’s Story - Blood Clots - 12 month(s) ago
I woke around 2 a.m. to use the restroom and I suddenly couldn’t see. I realized my night shirt was over my eyes and I was upside down. I had passed out.
Source: Blood ClotsCategories: Cardiology News and Journals, Latest HeadlinesTweet-
"The only words I could form were, 'God please help me,' then I passed out...After waking from a coma a few weeks later, I learned the rest of my story." Read Felecia's story: https://t.co/RrpBOTERDh #womenshealthmonth #stoptheclot #bloodclots #thrombectomy #DVT #PEsuvivor https://t.co/AgYWrE8UDH
-
-
Mashup Score: 0
Among patients with pulmonary embolism who underwent percutaneous thrombectomy, women experienced more procedure complications and mortality than men, according to study results published in CHEST.“Overall, considerable sex-based differences were present in the outcomes of patients with pulmonary embolism (PE) who underwent percutaneous pulmonary thrombectomy,” Manyoo A. Agarwal, MD,
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Women with pulmonary embolism who underwent percutaneous pulmonary artery #thrombectomy had increased procedural bleeding (16.9% vs. 11.2%), needed more blood transfusions (11.9% vs. 5.7%) and had more vascular complications (5% vs. 1.5%) than men. https://t.co/ppMEnpUd98
-
#California based Akura Medical secures $35M to pursue #FDA #clearance for #thrombectomy device - The money also will help fund clinical trials for additional indications and the expansion of its manufacturing capabilities | #stroke https://t.co/6SJCmPG9UK